Akari Therapeutics Plc Stock Probability of Future Stock Price Finishing Over 6.85
AKTX Stock | USD 1.12 0.04 3.45% |
Akari |
Akari Therapeutics Target Price Odds to finish over 6.85
The tendency of Akari Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current Price | Horizon | Target Price | Odds to move over $ 6.85 or more in 90 days |
1.12 | 90 days | 6.85 | near 1 |
Based on a normal probability distribution, the odds of Akari Therapeutics to move over $ 6.85 or more in 90 days from now is near 1 (This Akari Therapeutics PLC probability density function shows the probability of Akari Stock to fall within a particular range of prices over 90 days) . Probability of Akari Therapeutics PLC price to stay between its current price of $ 1.12 and $ 6.85 at the end of the 90-day period is about 98.0 .
Given the investment horizon of 90 days Akari Therapeutics has a beta of 0.27. This suggests as returns on the market go up, Akari Therapeutics average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Akari Therapeutics PLC will be expected to be much smaller as well. Additionally Akari Therapeutics PLC has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite. Akari Therapeutics Price Density |
Price |
Predictive Modules for Akari Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Akari Therapeutics PLC. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Akari Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Akari Therapeutics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Akari Therapeutics is not an exception. The market had few large corrections towards the Akari Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Akari Therapeutics PLC, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Akari Therapeutics within the framework of very fundamental risk indicators.α | Alpha over NYSE Composite | -1.34 | |
β | Beta against NYSE Composite | 0.27 | |
σ | Overall volatility | 0.50 | |
Ir | Information ratio | -0.3 |
Akari Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Akari Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Akari Therapeutics PLC can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.Akari Therapeutics generated a negative expected return over the last 90 days | |
Akari Therapeutics may become a speculative penny stock | |
Akari Therapeutics has high historical volatility and very poor performance | |
Akari Therapeutics has a very high chance of going through financial distress in the upcoming years | |
Net Loss for the year was (10.01 M) with profit before overhead, payroll, taxes, and interest of 0. | |
Akari Therapeutics PLC currently holds about 8.15 M in cash with (16.43 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.14. | |
Roughly 18.0% of the company shares are held by company insiders | |
Latest headline from MacroaxisInsider: Disposition of 5000000 shares by Dicicco Wendy F of Akari Therapeutics at 0.0017 subject to Rule 16b-3 |
Akari Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Akari Stock often depends not only on the future outlook of the current and potential Akari Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Akari Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding | 4.9 M | |
Cash And Short Term Investments | 3.8 M |
Akari Therapeutics Technical Analysis
Akari Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Akari Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Akari Therapeutics PLC. In general, you should focus on analyzing Akari Stock price patterns and their correlations with different microeconomic environments and drivers.
Akari Therapeutics Predictive Forecast Models
Akari Therapeutics' time-series forecasting models is one of many Akari Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Akari Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Akari Therapeutics PLC
Checking the ongoing alerts about Akari Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Akari Therapeutics PLC help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Akari Therapeutics generated a negative expected return over the last 90 days | |
Akari Therapeutics may become a speculative penny stock | |
Akari Therapeutics has high historical volatility and very poor performance | |
Akari Therapeutics has a very high chance of going through financial distress in the upcoming years | |
Net Loss for the year was (10.01 M) with profit before overhead, payroll, taxes, and interest of 0. | |
Akari Therapeutics PLC currently holds about 8.15 M in cash with (16.43 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.14. | |
Roughly 18.0% of the company shares are held by company insiders | |
Latest headline from MacroaxisInsider: Disposition of 5000000 shares by Dicicco Wendy F of Akari Therapeutics at 0.0017 subject to Rule 16b-3 |
Check out Akari Therapeutics Backtesting, Akari Therapeutics Valuation, Akari Therapeutics Correlation, Akari Therapeutics Hype Analysis, Akari Therapeutics Volatility, Akari Therapeutics History as well as Akari Therapeutics Performance. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Complementary Tools for Akari Stock analysis
When running Akari Therapeutics' price analysis, check to measure Akari Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Akari Therapeutics is operating at the current time. Most of Akari Therapeutics' value examination focuses on studying past and present price action to predict the probability of Akari Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Akari Therapeutics' price. Additionally, you may evaluate how the addition of Akari Therapeutics to your portfolios can decrease your overall portfolio volatility.
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |
Is Akari Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Akari Therapeutics. If investors know Akari will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Akari Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.04) | Return On Assets (1.16) | Return On Equity (12.81) |
The market value of Akari Therapeutics PLC is measured differently than its book value, which is the value of Akari that is recorded on the company's balance sheet. Investors also form their own opinion of Akari Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Akari Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Akari Therapeutics' market value can be influenced by many factors that don't directly affect Akari Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Akari Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Akari Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Akari Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.